MUTANOME.AI Trademark

Trademark Overview

On Saturday, July 12, 2025, a trademark application was filed for MUTANOME.AI with the United States Patent and Trademark Office. The USPTO has given the MUTANOME.AI trademark a serial number of 99280446. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 9, 2026. This trademark is owned by ThinkBio.Ai., Inc.. The MUTANOME.AI trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

AI-Powered platform that transforms raw genomic data into meaningful, functional insights. Mutanome.Ai integrates seamlessly into research and clinical workflows to deliver high-precision insights
mutanome.ai

General Information

Serial Number99280446
Word MarkMUTANOME.AI
Filing DateSaturday, July 12, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, January 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAI-Powered platform that transforms raw genomic data into meaningful, functional insights. Mutanome.Ai integrates seamlessly into research and clinical workflows to deliver high-precision insights
Pseudo MarkMUTANOME AI

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 12, 2025
Primary Code044
First Use Anywhere DateTuesday, July 1, 2025
First Use In Commerce DateTuesday, July 1, 2025

Trademark Owner History

Party NameThinkBio.Ai., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOntario, CA 91764

Trademark Events

Event DateEvent Description
Saturday, July 12, 2025NEW APPLICATION ENTERED
Saturday, July 12, 2025APPLICATION FILING RECEIPT MAILED
Friday, August 8, 2025TEAS AMENDMENT OF USE RECEIVED
Friday, August 8, 2025USE AMENDMENT FILED
Friday, August 8, 2025AMENDMENT TO USE PROCESSING COMPLETE
Monday, November 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 19, 2025ASSIGNED TO EXAMINER
Tuesday, November 25, 2025USE AMENDMENT ACCEPTED
Tuesday, November 25, 2025NON-FINAL ACTION WRITTEN
Tuesday, November 25, 2025NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 9, 2026NON-FINAL ACTION WRITTEN
Friday, January 9, 2026NON-FINAL ACTION E-MAILED
Friday, January 9, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

mutanome insights research seamlessly clinical workflows precision high deliver integrates